title: Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry.
abstract: Synthetic cannabinoids emerged on the designer drug market in recent years due to their ability to produce cannabis-like effects without the risk of detection by traditional drug testing techniques such as immunoassay and gas chromatography-mass spectrometry. As government agencies work to schedule existing synthetic cannabinoids, new, unregulated and structurally diverse compounds continue to be developed and sold. Synthetic cannabinoids undergo extensive metabolic conversion. Consequently, both blood and urine specimens may play an important role in the forensic analysis of synthetic cannabinoids. It has been observed that structurally similar synthetic cannabinoids follow common metabolic pathways, which often produce metabolites with similar metabolic transformations. Presented are two validated quantitative methods for extracting and identifying 15 parent synthetic cannabinoids in blood, 17 synthetic cannabinoid metabolites in urine and the qualitative identification of 2 additional parent compounds. The linear range for most synthetic cannabinoid compounds monitored was 0.1-10 ng/mL with the limit of detection between 0.01 and 0.5 ng/mL. Selectivity, specificity, accuracy, precision, recovery and matrix effect were also examined and determined to be acceptable for each compound. The validated methods were used to analyze a compilation of synthetic cannabinoid investigative cases where both blood and urine specimens were submitted. The study suggests a strong correlation between the metabolites detected in urine and the parent compounds found in blood.
authors.affiliation: Division of Forensic Toxicology, Armed Forces Medical Examiner System, 115 Purple Heart Drive, Dover, DE 19902, USA jessica.l.knittel.ctr@mail.mil.
authors.forename: Jessica L
authors.initials: JL
authors.lastname: Knittel
authors.affiliation: Division of Forensic Toxicology, Armed Forces Medical Examiner System, 115 Purple Heart Drive, Dover, DE 19902, USA.
authors.forename: Justin M
authors.initials: JM
authors.lastname: Holler
authors.affiliation: Division of Forensic Toxicology, Armed Forces Medical Examiner System, 115 Purple Heart Drive, Dover, DE 19902, USA.
authors.forename: Jeffrey D
authors.initials: JD
authors.lastname: Chmiel
authors.affiliation: Division of Forensic Toxicology, Armed Forces Medical Examiner System, 115 Purple Heart Drive, Dover, DE 19902, USA.
authors.forename: Shawn P
authors.initials: SP
authors.lastname: Vorce
authors.affiliation: Division of Forensic Toxicology, Armed Forces Medical Examiner System, 115 Purple Heart Drive, Dover, DE 19902, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Magluilo
authors.affiliation: Division of Forensic Toxicology, Armed Forces Medical Examiner System, 115 Purple Heart Drive, Dover, DE 19902, USA.
authors.forename: Barry
authors.initials: B
authors.lastname: Levine
authors.affiliation: Division of Forensic Toxicology, Armed Forces Medical Examiner System, 115 Purple Heart Drive, Dover, DE 19902, USA.
authors.forename: Gerardo
authors.initials: G
authors.lastname: Ramos
authors.affiliation: Division of Forensic Toxicology, Armed Forces Medical Examiner System, 115 Purple Heart Drive, Dover, DE 19902, USA.
authors.forename: Thomas Z
authors.initials: TZ
authors.lastname: Bosy
mesh_terms: D002186:Cannabinoids / Q000378:metabolism*; D002853:Chromatography, Liquid / Q000379:methods*; D015198:Designer Drugs / Q000378:metabolism; D006801:Humans; D053858:Metabolic Networks and Pathways; D053719:Tandem Mass Spectrometry / Q000379:methods*
chemical_list: D002186:Cannabinoids; D015198:Designer Drugs